VI
Vitrolife Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Thomas Axelsson, was filed 04 Oct 2018.
Vitrolife: what insiders have been doing
Insider filings for Vitrolife are scarce in the Finansinspektionen feed, the latest one published on 4 October 2018. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€7,953
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 4 October 2018
Declarations1 total
- 600 shares@ SEK 138.32100.0% of flowAktieFI:csv-acd9c583b99d9688b22eCanonical exit: 2 Jan 2019 (T+90)
1 of 1 declaration
About Vitrolife
Vitrolife is a company focused on developing products and services for fertility and reproductive biology. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations